Metropolitan Life Insurance CO Morphic Holding, Inc. Transaction History

Metropolitan Life Insurance CO

$2.27 Billion
Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 2,004 shares of MORF stock, worth $68,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,004

Previous 2,004 -0.0%

Holding current value

$68,276

Previous $57,000 22.81%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $7,273 - $20,262	341 Added 20.51%	2,004 $45,000
Q2 2023 Aug 10, 2023	BUY	$34.33 - $62.11 $9,715 - $17,577	283 Added 20.51%	1,663 $95,000
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $5,748 - $10,760	-221 Reduced 13.8%	1,380 $51,000
Q4 2022 Jun 14, 2023	BUY	$24.14 - $30.37 $5,334 - $6,711	221 Added 16.01%	1,601 $42.8 Million
Q4 2022 Mar 30, 2023	BUY	$24.14 - $30.37 $5,165 - $6,499	214 Added 15.43%	1,601 $42,000

Q4 2022 Feb 15, 2023	BUY	$24.14 - $30.37 $5,165 - $6,499	214 Added 15.43%	1,601 $42,000
Q3 2022 Jun 14, 2023	BUY	$22.23 - $33.37 $155 - $233	7 Added 0.51%	1,387 $39.3 Million
Q2 2022 Jun 20, 2023	BUY	$19.74 - $43.01 $138 - $301	7 Added 0.51%	1,387 $30,000
Q1 2022 Jun 20, 2023	BUY	$36.25 - $52.02 $253 - $364	7 Added 0.51%	1,387 $55,000
Q1 2022 Mar 30, 2023	SELL	$36.25 - $52.02 $162,798 - $233,621	-4,491 Reduced 76.4%	1,387 $55,000
Q1 2022 May 12, 2022	SELL	$36.25 - $52.02 $162,798 - $233,621	-4,491 Reduced 76.4%	1,387 $56,000
Q4 2021 Jun 21, 2023	BUY	$43.27 - $65.72 $194,628 - $295,608	4,498 Added 325.94%	5,878 $278,000
Q3 2021 Jun 21, 2023	BUY	$53.61 - $67.5 $241,137 - $303,615	4,498 Added 325.94%	5,878 $332,000
Q2 2021 Jun 21, 2023	BUY	$45.13 - $64.99 $202,994 - $292,325	4,498 Added 325.94%	5,878 $337,000
Q2 2021 Mar 30, 2023	BUY	$45.13 - $64.99 $70,041 - $100,864	1,552 Added 35.88%	5,878 $337,000
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $265,093 - $381,751	5,874 Added 146850.0%	5,878 $337,000
Q1 2021 Jun 26, 2023	BUY	$29.77 - $84.85 $87,702 - $249,968	2,946 Added 213.48%	4,326 $274 Million
Q1 2021 Mar 30, 2023	SELL	$29.77 - $84.85 $7,531 - $21,467	-253 Reduced 5.53%	4,326 $273,000
Q1 2021 May 14, 2021	SELL	$29.77 - $84.85 $136,197 - $388,188	-4,575 Reduced 99.91%	4 $274,000
Q4 2020 Jun 22, 2023	BUY	$25.66 - $34.55 $82,086 - $110,525	3,199 Added 231.81%	4,579 $153,000
Q3 2020 Jun 26, 2023	BUY	$22.51 - $30.11 $72,009 - $96,321	3,199 Added 231.81%	4,579 $125,000
Q2 2020 Jun 26, 2023	BUY	$12.65 - $29.57 $40,467 - $94,594	3,199 Added 231.81%	4,579 $123,000
Q2 2020 Mar 30, 2023	BUY	$12.65 - $29.57 $37,671 - $88,059	2,978 Added 186.01%	4,579 $123,000
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $57,924 - $135,401	4,579 New	4,579 $124,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account

Metropolitan Life Insurance CO Morphic Holding, Inc. Transaction History